Professional
Added to YB: 2025-06-27
Pitch date: 2025-06-24
NUVB [neutral]
Nuvation Bio Inc.
-4.43%
current return
Author Info
ToffCap are full-time fund managers finding undervalued opportunities and a reason why the price should (start to) move in the right direction. Sign up for their newsletter.
Company Info
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
Market Cap
$697.5M
Pitch Price
$2.03
Price Target
7.50 (+285%)
Dividend
N/A
Sector
Pharmaceuticals
Category
special_situation
NUVB: Heavy Insider Buying and Street Targets Signal Major Rebound Potential
$NUVB (quick pitch): Insiders making BIG open market purchases. Stock price melting with cash. AnHeart acquisition last year drove large price reaction. Revenue coming soon. Sell-side increasing price target with +300% upside potential.
Read full article (1 min)